Cargando…
Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer
SIMPLE SUMMARY: Despite the availability of numerous therapeutic approaches, pancreatic ductal adenocarcinoma still stands as one of the most fatal cancers worldwide. Nanoliposomes could potentially be helpful in improving the pharmacokinetic and anticancer efficacy of drug molecules. Gemcitabine is...
Autores principales: | Patel, Akanksha, Saraswat, Aishwarya, Patel, Harsh, Chen, Zhe-Sheng, Patel, Ketan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818435/ https://www.ncbi.nlm.nih.gov/pubmed/36612178 http://dx.doi.org/10.3390/cancers15010182 |
Ejemplares similares
-
Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy
por: Saraswat, Aishwarya, et al.
Publicado: (2022) -
Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro
por: Vartak, Richa, et al.
Publicado: (2021) -
Gemcitabine elaidate and ONC201 combination therapy inhibits pancreatic cancer in a KRAS mutated syngeneic mouse model
por: Mahato, Ram, et al.
Publicado: (2023) -
In Vitro Assessment of Cisplatin/Hyaluronan Complex for Loco-Regional Chemotherapy
por: Banella, Sabrina, et al.
Publicado: (2023) -
Vaccines targeting the neovasculature of tumors
por: Matejuk, Agata, et al.
Publicado: (2011)